SIM
VERA icon

Sandia Investment Management’s Vera Therapeutics VERA Stock Holding History

Sandia Investment Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$127K Buy
+2,500
New +$88.8K 0.32% 93
2025
Q1 		– Sell
-10,000
Closed -$423K – 121
2024
Q4 		$423K Buy
+10,000
New +$443K 0.8% 31
2023
Q2 		– Sell
-10,000
Closed -$77.6K – 271
2023
Q1 		$77.6K Buy
+10,000
New +$77.2K 0.01% 186

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Sandia Investment Management's VERA Position: Q4 2025 in Review

Sandia Investment Management opened a new position in Vera Therapeutics (VERA) in Q4 2025: 2,500 shares worth $127K. The stake represents 0.32% of the portfolio and ranks #93 among its holdings. This is a return to the name: Sandia Investment Management previously reported a position in VERA as recently as Q4 2024.

Sandia Investment Management first reported a position in VERA in Q1 2023 and has held it in 3 quarters since. The position peaked at $423K in Q4 2024. 214 funds tracked by Wall St. Rank hold VERA as of Q4 2025.

  • Sandia Investment Management held 2,500 shares of Vera Therapeutics worth $127K as of Q4 2025.
  • Vera Therapeutics was a new Sandia Investment Management position in Q4 2025.
  • Vera Therapeutics made up 0.32% of Sandia Investment Management's portfolio in Q4 2025, its #93 holding.
  • Sandia Investment Management first reported a position in Vera Therapeutics in Q1 2023 and has held it in 3 quarters since.
  • Sandia Investment Management's Vera Therapeutics position peaked at $423K in Q4 2024.
  • 214 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2025.

Based on Sandia Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.